Statistics

Total Visits

Views
Tenofovir DF prevents HBV reactivation in anti-HBc positive patients with hematologic malignancies treated with Rituximab: 12-months results of a randomized study (PREBLIN study)64

Select a period of time:

Number of views in the range

Views
Tenofovir DF prevents HBV reactivation in anti-HBc positive patients with hematologic malignancies treated with Rituximab: 12-months results of a randomized study (PREBLIN study)11

Views

Views
November 20250
December 20251
January 20260
February 20260
March 20267
April 20261
May 20262
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States6
Chile1
Algeria1
France1
United Kingdom1
Venezuela1
 

Top cities views

Views
Barquisimeto1
Meridian1
Quilicura1